Search for Clinical Trial Results
Fallopian Tube Diseases - 25 Studies Found
Status | Study |
Not yet recruiting |
Study Name: A Study of Olaparib Prior to Surgery and Chemotherapy in Ovarian, Primary Peritoneal, and Fallopian Tube Cancer Condition:
|
Terminated |
Study Name: Phase 2 Trial of Regorafenib in Patients With Recurrent Ovarian, Primary Peritoneal and Fallopian Tube Cancer Condition:
|
Active, not recruiting |
Study Name: Dose-Escalation Study of Intraperitoneal (IP) Cisplatin, IV/IP Paclitaxel, IV Bevacizumab, and Oral Olaparib for Newly Diagnosed Ovarian, Primary Peritoneal, and Fallopian Tube Cancer Condition:
|
Recruiting |
Study Name: Enzalutamide in Patients With Androgen Receptor Positive (AR+) Ovarian, Primary Peritoneal or Fallopian Tube Cancer and One, Two or Three Prior Therapies Condition:
|
Completed |
Study Name: A Study of Demcizumab Plus Paclitaxel in Subjects With Platinum Resistant Ovarian Condition: Primary Peritoneal Carcinoma Date: 2013-09-18 Interventions:
|